Radiofrequency waves tested as a Drug-Free pain relief for new mothers
NCT ID NCT07730372
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This trial investigates whether TECAR therapy, a form of radiofrequency energy, can reduce pain and discomfort in women who have perineal tears or episiotomies after vaginal delivery. Around 180 women are randomly assigned to receive the therapy, a sham treatment, or standard care. Pain levels are measured at rest, sitting, and walking over the first two days and again six to eight weeks after birth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- TECAR therapy (capacitive and resistive energy transfer) using a radiofrequency device
- What this could lead to
- If effective, TECAR therapy could offer a drug-free option to reduce pain and discomfort after childbirth-related perineal trauma.
- What could go wrong
- This is a small, early-stage trial. The sham and control groups help test if any benefit is real, but results may not apply broadly. Radiofrequency therapy is generally safe but may cause mild skin irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
182 people
The number who actually took part.
- Started
-
Jul 2022
- Finished
-
Sep 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * vaginal birth (including assisted brith - forcebs or vacuum) * perineal injury (tear or episiotomy) * presence of perineal pain * no contraindications to TECAR therapy Exclusion Criteria: * cesarean cection * perineal protection * lack of pain * contraindications to TECAR therapy: presence of electronic devices in the body, coagulation disorders (hemophilia, von Willebrand disease, use of anticoagulants), burns in the examined area, malignancy, severe hypertension or hypotension, and thrombophlebitis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Episiotomy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Clinical Center
Gdansk, Pomeranian, 80-214, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gel vs ointment: which helps new mothers heal faster after episiotomy?
- A new weapon against birth tears? pelvic floor training put to the test
- Could a boric acid dressing soothe Post-Birth pain and speed healing?
- A quick ultrasound during labor may predict perineal tears and C-Section risk
- Walking and mental imagery may tame Post-Cancer bowel troubles
- A shot of your own blood may heal birth tears faster